Effect of disease‐modifying anti‐rheumatic drugs on therapeutic outcomes among women with endometriosis
article
OA: closed
CC0
⤵ 4 in-corpus citations
Abstract
OBJECTIVE: To determine whether disease-modifying anti-rheumatic drugs (DMARDs) affect the use of hormonal treatments, subsequent ablative surgery, and need for pain management, including opioids, non-steroidal anti-inflammatory drugs and anti-depressants, among women with endometriosis. METHODS: In a retrospective study, data were reviewed from women with surgically confirmed endometriosis who were not treated (n=234) or treated with DMARDs for 6 weeks or more (n=25) before surgical diagnosis at a single healthcare system in the USA between 2003 and 2013. The postoperative use of hormonal treatments, proportion of women undergoing subsequent ablative surgery, and use of adjunct therapies such as antidepressants, steroids, and opioids after surgery were compared between the two groups. RESULTS: The two groups showed differences in age (P=0.007) and follow-up time (P<0.001). Univariate analysis showed more frequent use of hormonal treatments (P=0.045) and antidepressants (P=0.006) among women treated with DMARDs. The frequency of post-diagnostic use of opioids was lower among treated women (P=0.001); this association remained significant in multivariate analysis controlling for potential confounders (P=0.003). CONCLUSION: The findings suggest that administration of DMARDs for at least 6 weeks is associated with decreased opioid usage among women with endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo via openalex
- Autoimmunity to endometrium and ovary in endometriosis. via openalex
- Autoimmunity to Endometrium and Ovary in Endometriosis via openalex
- Autoreactivity in women with endometriosis via openalex
- Endometriosis via openalex
- Immunology of endometriosis via openalex
- Impact of endometriosis on women’s lives: a qualitative study via openalex
- Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study via openalex
- Localization of anti‐endometrial antibody binding in women with endometriosis using a double‐labelling immunohistochemical method via openalex
- Pentoxifylline versus medical therapies for subfertile women with endometriosis via openalex
- Peritoneal fluid and serum autoantibody levels in patients with endometriosis via openalex
- The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome via openalex
- W2121175478 via openalex
- W2187103524 via openalex
- W2401134385 via openalex
- W2406530610 via openalex
- W2407530191 via openalex
- W2417327597 via openalex
- W2009551417 via openalex
- W100098653 via openalex
- W2018416312 via openalex
- W2055833776 via openalex
- W2075836508 via openalex
- W2076218729 via openalex
- W2090920511 via openalex
- W2096980318 via openalex
Cited by (4)
- The effectiveness of 10 mg prednisolone on pelvic pain reduction in women with deep infiltrative endometriosis: A randomized clinical trial 2025
- The latest advances in the pharmacological management of endometriosis 2022
- Pentoxifylline for the treatment of endometriosis-associated pain and infertility 2021
- Evidence for an association between endometriosis, fibromyalgia, and autoimmune diseases 2019
SciLite annotations
chemicals 2
steroid
opioid analgesic
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:20:07.505861+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00
License: CC0
· commercial use OK